Clinical Scientist in microbiology. Interests: AMR; epidemiology of Gram-negatives; diagnostics for resistance detection. Views my own. @theamrdoc@mstdn.science
🆕💫Antimicrobial Susceptibility of Clinical Isolates of Stenotrophomonas maltophilia Isolates /Europe, Asia,Latin America (2018–2023)
1,287 clinical isolates
71 medical centres 🌎
Aztreonam-avibactam most active 99.5%
Bactrim 95.6/96.3% S per CLSI/EUCAST
ijidonline.com/article/S1201…
The Sanger Prize Competition 2025 - calling for undergraduate students in LMICs
The winner will be offered a 3month internship with travel, living and research expenses are all covered by the award. sanger.ac.uk/about/the-sange…#sangerinstitute
PUBLISHED: The 2023-24 English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report gov.uk/government/publicatio…
Register to find out more about the findings in the report at the webinar we are hosting on 20th November: antibioticguardian.com/Meeti…
The increasing report of NDM-producing E. coli isolates that are resistant to either aztreonam-avibactam and/or cefiderocol is major source of concern!
Potent in-vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli #idxpostsclinicalmicrobiologyandinfec…
Come join us at the UK’s national reference lab for AMR and HCAIs - permanent AfC8b Clinical Scientist role leading Staph and Strep Service.
Apply here: beta.jobs.nhs.uk/candidate/j…
We are running a massive online open course on AMR databases starting end of the month. Its completely free, study at your own pace and its ~15 hours overall over the 3 weeks (although you can finish any time in a year). Please spread in your networks! coursesandconferences.wellco…
Exciting times! A big paper I was involved in has dropped @NatureMicrobiol.
100 cases of phage therapy facilitated by a Belgian consortium showing 77.2% clinical improvement. I will go through the results below put please read 👇
nature.com/articles/s41564-0…
Responsibilities to include technical work in the in-vitro evaluation of:
- novel antimicrobial
- antimicrobial susceptibility testing kits
- molecular testing kits/systems for detecting resistance determinants
- or surveillance of antimicrobial resistance.
We are delivering a 6-part Global Antimicrobial Resistance webinar series with speakers from the UK and countries around the world. If you would like to learn more about webinar 6 -
Evaluating an Antimicrobial Stewardship Programme, please click here ow.ly/tJzS50RazYr
The updated Bacterial Priority Pathogens List features 15 families of antibiotic-resistant bacteria.
To guide the development of new treatments to prevent #AntimicrobialResistance, it sorts them into priorities:
🚨 critical
🔴 high
🟠 medium
More about the list and #AMR: bit.ly/4apqHoQ
#IDTwitter
I always thought of SUL-DUR as a 🦀 agent only.
I’ve yet to see an NDM E. coli w/ PBP3 mutation, but I’m sure it’s just a matter of time b4 it pops up in Chicago
Good to know that durlobactam may work @OncDPharmd @jpogue1 @ryankshieldsdoi.org/10.1093/cid/ciae229
In vitro-in vivo discordance in β-lactams activities against MBL producing Enterobacterales has been described
🔥Deciphering the Efficacy of β-Lactams in the Face of MBL Derived Resistance in Enterobacterales
Supraphysiologic Zinc in Broth is the Culprit🔥 academic.oup.com/ofid/articl…